Back to top
more

Alignment Healthcare (ALHC)

(Delayed Data from NSDQ)

$12.97 USD

12.97
3,566,563

-0.81 (-5.88%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $12.96 -0.01 (-0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

CareDx (CDNA) Soars 20.6%: Is Further Upside Left in the Stock?

by Zacks Equity Research

CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 20% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Strength Seen in Alignment Healthcare (ALHC): Can Its 6.5% Jump Turn into More Strength?

by Zacks Equity Research

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Alignment Healthcare (ALHC) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -3.33% and 6.10%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates

by Zacks Equity Research

NovoCure (NVCR) delivered earnings and revenue surprises of -12.50% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Alignment Healthcare (ALHC) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 12% and 8%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit

by Zacks Equity Research

Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.

Zacks Equity Research

UnitedHealth (UNH) Wins New Medicaid Contract in Nebraska

by Zacks Equity Research

UnitedHealth's (UNH) UnitedHealthcare boasts a network of 100 hospitals and more than 14,000 physicians and caregivers in Nebraska.

Zacks Equity Research

Encompass Health (EHC) Opens New 50-Bed Hospital in Naples

by Zacks Equity Research

With the new facility in Naples, Encompass Health (EHC) now has 153 inpatient rehabilitation units in total.

Zacks Equity Research

HCA Healthcare (HCA) Invests in VitalConnect's Remote Monitoring

by Zacks Equity Research

HCA Healthcare's (HCA) investment is likely to advance technology in the medical space, helping patients as well as professionals.

Zacks Equity Research

Is Aerie Pharmaceuticals (AERI) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Aerie Pharmaceuticals (AERI) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.

Zacks Equity Research

Is Alignment Healthcare (ALHC) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Alignment Healthcare (ALHC) and Hanger (HNGR) have performed compared to their sector so far this year.

Zacks Equity Research

Wall Street Analysts See a 33% Upside in Alignment Healthcare (ALHC): Can the Stock Really Move This High?

by Zacks Equity Research

The consensus price target hints at a 32.9% upside potential for Alignment Healthcare (ALHC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Has Alignment Healthcare (ALHC) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Alignment Healthcare (ALHC) and BioCryst Pharmaceuticals (BCRX) have performed compared to their sector so far this year.

Zacks Equity Research

Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 76.92% and 8.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 4.17% and 3.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Alignment Healthcare (ALHC) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.